scholarly article | Q13442814 |
P356 | DOI | 10.1067/MCP.2003.27 |
P698 | PubMed publication ID | 12621387 |
P2093 | author name string | Michel Eichelbaum | |
Martin F Fromm | |||
Hartmut Glaeser | |||
Thomas Mürdter | |||
Monika Hitzl | |||
Siegfried Drescher | |||
P433 | issue | 3 | |
P407 | language of work or name | English | Q1860 |
P921 | main subject | digoxin | Q422222 |
P304 | page(s) | 223-231 | |
P577 | publication date | 2003-03-01 | |
P1433 | published in | Clinical Pharmacology & Therapeutics | Q1101529 |
P1476 | title | P-glycoprotein-mediated intestinal and biliary digoxin transport in humans | |
P478 | volume | 73 |
Q44231662 | A novel screening strategy to identify ABCB1 substrates and inhibitors |
Q50924621 | A pharmacokinetic interaction study of ticagrelor and digoxin in healthy volunteers. |
Q24799859 | Association between the number of coadministered P-glycoprotein inhibitors and serum digoxin levels in patients on therapeutic drug monitoring |
Q64107533 | Changes in the Expression of Aquaporin-3 in the Gastrointestinal Tract Affect Drug Absorption |
Q37993655 | Circadian clock genes and implications for intestinal nutrient uptake |
Q91069615 | Clinical Aspects of Transporter-Mediated Drug-Drug Interactions |
Q35620664 | Clinical relevance of P-glycoprotein in drug therapy |
Q35776626 | Complex drug interactions of the HIV protease inhibitors 3: effect of simultaneous or staggered dosing of digoxin and ritonavir, nelfinavir, rifampin, or bupropion |
Q49369243 | Different modulation of Panax notoginseng on the absorption profiling of triptolide and tripterine from Tripterygium wilfordii in rat intestine |
Q33942474 | Diurnal rhythmicity in the transcription of jejunal drug transporters |
Q36419290 | Drug transporters in pharmacokinetics |
Q89336517 | Effect of carbamazepine on the pharmacokinetics of paliperidone extended-release tablets at steady-state |
Q46807639 | Effect of lasofoxifene on the pharmacokinetics of digoxin in healthy postmenopausal women |
Q46743429 | Effects of pregnancy on CYP3A and P-glycoprotein activities as measured by disposition of midazolam and digoxin: a University of Washington specialized center of research study |
Q45188831 | Evaluation of first-pass cytochrome P4503A (CYP3A) and P-glycoprotein activities using alfentanil and fexofenadine in combination |
Q37705351 | Evaluation of in vivo P-glycoprotein phenotyping probes: a need for validation |
Q51735063 | Further Study of Influence of Panax notoginseng on Intestinal Absorption Characteristics of Triptolide and Tripterine in Rats with Tripterygium wilfordii. |
Q40895593 | Gastrointestinal absorption and metabolism of hesperetin-7-O-rutinoside and hesperetin-7-O-glucoside in healthy humans |
Q28176037 | Herb-drug interactions: a literature review |
Q37811970 | In Vivo Probes of Drug Transport: Commonly Used Probe Drugs to Assess Function of Intestinal P-glycoprotein (ABCB1) in Humans |
Q60787030 | Increased absorption of digoxin from the human jejunum due to inhibition of intestinal transporter-mediated efflux |
Q42129498 | Influence of rifampicin on the expression and function of human intestinal cytochrome P450 enzymes |
Q40184411 | Intestinal drug transporter expression and the impact of grapefruit juice in humans |
Q36985043 | Intestinal permeability and its relevance for absorption and elimination |
Q36960535 | Maximising use of in vitro ADMET tools to predict in vivo bioavailability and safety |
Q57726142 | Metabolic and Efflux Properties of Caco-2 Cells Stably Transfected with Nuclear Receptors |
Q36495774 | Methods to evaluate biliary excretion of drugs in humans: an updated review |
Q37515418 | Organic cation transporters and their roles in antiretroviral drug disposition |
Q34349313 | Overcoming drug resistance by regulating nuclear receptors |
Q46922851 | Pharmacodynamics of carbamazepine-mediated induction of CYP3A4, CYP1A2, and Pgp as assessed by probe substrates midazolam, caffeine, and digoxin |
Q37957801 | Pharmacokinetic considerations in Roux-en-Y gastric bypass patients |
Q33204911 | Pharmacokinetic interactions of drugs with St John's wort |
Q56832659 | Plasma LDL cholesterol has no impact on P-glycoprotein (MDR1/ABCB1) activity in human peripheral blood mononuclear cells |
Q37139856 | Prediction of human pharmacokinetics-biliary and intestinal clearance and enterohepatic circulation |
Q33267032 | Prognostic significance of multidrug-resistance protein (MDR-1) in renal clear cell carcinomas: a five year follow-up analysis. |
Q44653786 | Rifampicin reduces plasma concentrations of celiprolol |
Q39542449 | Rifampin and digoxin induction of MDR1 expression and function in human intestinal (T84) epithelial cells. |
Q48301397 | Rifampin's acute inhibitory and chronic inductive drug interactions: experimental and model-based approaches to drug-drug interaction trial design. |
Q46578287 | Role of enterohepatic recirculation in drug disposition: cooperation and complications |
Q46890019 | Role of p-glycoprotein inhibition for drug interactions: evidence from in vitro and pharmacoepidemiological studies |
Q28269209 | Simultaneous measurement of in vivo P-glycoprotein and cytochrome P450 3A activities |
Q34657381 | Sucralose, a synthetic organochlorine sweetener: overview of biological issues |
Q38156114 | Suitability of digoxin as a P-glycoprotein probe: implications of other transporters on sensitivity and specificity |
Q35956193 | The ABC transporters MDR1 and MRP2: multiple functions in disposition of xenobiotics and drug resistance |
Q37669983 | The Effects of Pregnenolone 16α-Carbonitrile Dosing on Digoxin Pharmacokinetics and Intestinal Absorption in the Rat. |
Q80201270 | The association of ABCB1 polymorphisms and elevated serum digitoxin concentrations in geriatric patients |
Q39655447 | The impact of thyroid disease on the regulation, expression, and function of ABCB1 (MDR1/P glycoprotein) and consequences for the disposition of digoxin |
Q37905033 | Transporter-mediated drug-drug interactions |
Search more.